Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma
- PMID: 19733416
- DOI: 10.1016/j.lungcan.2009.08.007
Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma
Comment on
-
Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent.Lung Cancer. 2009 May;64(2):211-8. doi: 10.1016/j.lungcan.2008.08.013. Epub 2008 Nov 29. Lung Cancer. 2009. PMID: 19042053 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
